Headquarters: Haifa, Israel
Investor Relations: Dana Rubin / +972-74-7107194 / danar@pluristem.com

Description
Pluristem’s cell therapies advance the field of regenerative medicine, with potentially groundbreaking applications for treating damaged muscle, hematology deficiencies, and inflammation. Pluristem sources its therapeutic cells from the placenta, an ethically accepted and potent source.
Industry
Life Sciences
Year Founded
Website
Ownership
Public
Exchange / Symbol
Pluristem’s cell therapies advance the field of regenerative medicine, with potentially groundbreaking applications for treating damaged muscle, hematology deficiencies, and inflammation. Pluristem sources its therapeutic cells from the placenta, an ethically accepted and potent source.